DK1861080T3 - Idebenon til behandling af muskeldystrofier - Google Patents

Idebenon til behandling af muskeldystrofier

Info

Publication number
DK1861080T3
DK1861080T3 DK06723554.9T DK06723554T DK1861080T3 DK 1861080 T3 DK1861080 T3 DK 1861080T3 DK 06723554 T DK06723554 T DK 06723554T DK 1861080 T3 DK1861080 T3 DK 1861080T3
Authority
DK
Denmark
Prior art keywords
idebenone
treatment
muscular dystrophies
treating
muscular dystrophy
Prior art date
Application number
DK06723554.9T
Other languages
English (en)
Inventor
Thomas Meier
Gunnar Buyse
Original Assignee
Santhera Pharmaceuticals Ch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36572153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1861080(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Santhera Pharmaceuticals Ch filed Critical Santhera Pharmaceuticals Ch
Application granted granted Critical
Publication of DK1861080T3 publication Critical patent/DK1861080T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK06723554.9T 2005-03-21 2006-03-20 Idebenon til behandling af muskeldystrofier DK1861080T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05006137 2005-03-21
PCT/EP2006/002536 WO2006100017A1 (en) 2005-03-21 2006-03-20 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies

Publications (1)

Publication Number Publication Date
DK1861080T3 true DK1861080T3 (da) 2010-09-06

Family

ID=36572153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06723554.9T DK1861080T3 (da) 2005-03-21 2006-03-20 Idebenon til behandling af muskeldystrofier

Country Status (17)

Country Link
US (1) US7977388B2 (da)
EP (1) EP1861080B1 (da)
JP (1) JP4896123B2 (da)
AT (1) ATE468849T1 (da)
AU (1) AU2006226623B2 (da)
CA (1) CA2602290C (da)
CY (1) CY1110182T1 (da)
DE (1) DE602006014514D1 (da)
DK (1) DK1861080T3 (da)
ES (1) ES2345353T3 (da)
MX (1) MX2007011571A (da)
NZ (1) NZ561235A (da)
PL (1) PL1861080T3 (da)
PT (1) PT1861080E (da)
SI (1) SI1861080T1 (da)
WO (1) WO2006100017A1 (da)
ZA (1) ZA200707833B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101534843A (zh) 2006-08-01 2009-09-16 普里克萨斯医药股份有限公司 泊洛沙姆用于预防和/或治疗心力衰竭的用途
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
EP2234625B8 (en) * 2007-12-17 2013-10-30 The Regents of the University of Michigan Compositions and methods for treating and preventing skeletal muscle deficiencies
ES2370607T3 (es) * 2008-04-09 2011-12-20 Santhera Pharmaceuticals (Schweiz) Ag Idebenona para el tratamiento de enfermedad respiratoria en distrofia muscular.
EP2246048A1 (en) 2009-04-30 2010-11-03 Santhera Pharmaceuticals (Schweiz) AG Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
HRP20161407T1 (hr) 2010-08-16 2016-12-02 Santhera Pharmaceuticals (Schweiz) Ag Derivati benzokinona za liječenje mitohondrijskih bolesti oka
CN103086861B (zh) * 2012-11-12 2015-09-16 刘炜 羟癸基苯醌衍生物及其用途
WO2021127003A1 (en) * 2019-12-16 2021-06-24 Children's Medical Center Corporation Treating heart disease in muscular dystrophy patients
WO2022258629A1 (en) 2021-06-07 2022-12-15 Katholieke Universiteit Leuven Idebenone in the treatment of drug resistant epilepsy
CN113827585B (zh) * 2021-10-27 2023-04-11 山东大学齐鲁医院 艾地苯在治疗肢带型肌营养不良2g型中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11116470A (ja) 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
AU8562998A (en) 1997-08-12 1999-03-01 Takeda Chemical Industries Ltd. Idebenone-containing preparation for percutaneous administration
US20030013772A1 (en) * 2000-02-23 2003-01-16 Murphy Michael A. Composition, synthesis and therapeutic applications of polyamines
CA2272971C (en) * 1998-10-29 2008-01-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
US20040081961A1 (en) * 2001-05-04 2004-04-29 Delegeane Angelo M Proteases
EP1618881A1 (en) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Use of non-glucocorticoid steroids for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
US7977388B2 (en) 2011-07-12
AU2006226623B2 (en) 2010-04-22
PT1861080E (pt) 2010-06-17
US20090012050A1 (en) 2009-01-08
EP1861080A1 (en) 2007-12-05
DE602006014514D1 (da) 2010-07-08
AU2006226623A1 (en) 2006-09-28
JP4896123B2 (ja) 2012-03-14
CA2602290C (en) 2012-01-17
NZ561235A (en) 2010-12-24
ZA200707833B (en) 2008-06-25
PL1861080T3 (pl) 2010-10-29
MX2007011571A (es) 2007-12-06
EP1861080B1 (en) 2010-05-26
ES2345353T3 (es) 2010-09-21
WO2006100017A1 (en) 2006-09-28
ATE468849T1 (de) 2010-06-15
JP2008533182A (ja) 2008-08-21
CA2602290A1 (en) 2006-09-28
SI1861080T1 (sl) 2010-08-31
CY1110182T1 (el) 2015-01-14

Similar Documents

Publication Publication Date Title
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
IL232313A (en) Modulators of indoleamine 2,3-dioxigenase and methods of use of the above
PT1978947E (pt) Derivados nitro-óxido para utilização no tratamento de distrofias musculares
EP1731113B8 (en) Medical treatment kit
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
IL196965A (en) Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure
EP1912650B8 (en) Use of flibanserin in the treatment of obesity
CL2008002353A1 (es) Compuestos derivados de 7h-indolo[2,1-a][2]benzazepina; composicion farmaceutica; y uso en el tratamiento de la hepatitis c.
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
CL2007002769A1 (es) Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
BRPI0913297A2 (pt) composição, farmacêutica, uso de uma composição, e, kit terapêutico.
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
BRPI0719997A2 (pt) Uso de epotilonas no tratamento de osteoporose e doenças relacionadas
WO2006060084A3 (en) Coadministration of tigecycline and digoxin
IL178190A0 (en) Medical plaster for application on the skin
EP1908467A4 (en) Herpesvirus-derived therapeutic agent for pain
GB0405405D0 (en) Assays and medical treatments
CL2007003284A1 (es) Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas.
GB0401792D0 (en) Medical treatment
GB0401807D0 (en) Medical treatment